These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22669160)

  • 21. MDK Protein Overexpression Correlates with the Malignant Status and Prognosis of Non-small Cell Lung Cancer.
    Yuan K; Chen Z; Li W; Gao CE; Li G; Guo G; Yang Y; Ai Y; Wu L; Zhang M
    Arch Med Res; 2015 Nov; 46(8):635-41. PubMed ID: 26656665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Implications of FADD Gene Amplification and Protein Overexpression in Taiwanese Oral Cavity Squamous Cell Carcinomas.
    Chien HT; Cheng SD; Chuang WY; Liao CT; Wang HM; Huang SF
    PLoS One; 2016; 11(10):e0164870. PubMed ID: 27764170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.
    Lee HJ; Choe G; Jheon S; Sung SW; Lee CT; Chung JH
    J Thorac Oncol; 2010 May; 5(5):649-57. PubMed ID: 20354454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
    Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
    Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of G-protein-signaling modulator 2 promotes metastasis of non-small-cell lung cancer by inducing the expression of Snail.
    Deng M; Liu B; Zhang Z; Chen Y; Wang Y; Wang X; Lv Q; Yang X; Hou K; Che X; Qu X; Liu Y; Zhang Y; Hu X
    Cancer Sci; 2020 Sep; 111(9):3210-3221. PubMed ID: 32519357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.
    Hu R; Huffman KE; Chu M; Zhang Y; Minna JD; Yu Y
    J Proteome Res; 2016 Feb; 15(2):477-86. PubMed ID: 26736068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infiltrating immune cells, but not tumour cells, express FasL in non-small cell lung cancer: No association with prognosis identified in 3-year follow-up.
    Toomey D; Smyth G; Condron C; Kelly J; Byrne AM; Kay E; Conroy RM; Broe P; Bouchier-Hayes D
    Int J Cancer; 2003 Jan; 103(3):408-12. PubMed ID: 12471625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GIT1 promotes lung cancer cell metastasis through modulating Rac1/Cdc42 activity and is associated with poor prognosis.
    Chang JS; Su CY; Yu WH; Lee WJ; Liu YP; Lai TC; Jan YH; Yang YF; Shen CN; Shew JY; Lu J; Yang CJ; Huang MS; Lu PJ; Lin YF; Kuo ML; Hua KT; Hsiao M
    Oncotarget; 2015 Nov; 6(34):36278-91. PubMed ID: 26462147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
    Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C
    Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
    Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
    Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-expression of ILT4/HLA-G in human non-small cell lung cancer correlates with poor prognosis and ILT4-HLA-G interaction activates ERK signaling.
    Zhang Y; Zhao J; Qiu L; Zhang P; Li J; Yang D; Wei X; Han Y; Nie S; Sun Y
    Tumour Biol; 2016 Aug; 37(8):11187-98. PubMed ID: 26939901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of cytochrome c oxidase subunit Va in non-small cell lung carcinoma cells: association with migration, invasion and prediction of distant metastasis.
    Chen WL; Kuo KT; Chou TY; Chen CL; Wang CH; Wei YH; Wang LS
    BMC Cancer; 2012 Jun; 12():273. PubMed ID: 22748147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear markers (star volume, mitotic index, AgNOR and Ki-67) of the primary tumor and its metastasis in non-small cell lung carcinomas.
    Matheus RS; Bernardi Fdel C; Gallo CP; da Silva AP; Rodrigues OR; Capelozzi M; Lopes A; Fenezelian S; Saldiva PH; Capelozzi VL
    Pathol Res Pract; 2004; 200(1):13-23. PubMed ID: 15157046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of DR5 and c‑FLIP proteins as novel prognostic biomarkers for non‑small cell lung cancer patients treated with surgical resection and chemotherapy.
    Zheng H; Zhang Y; Zhan Y; Liu S; Lu J; Wen Q; Fan S
    Oncol Rep; 2019 Dec; 42(6):2363-2370. PubMed ID: 31638235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma.
    Glatzel-Plucinska N; Piotrowska A; Grzegrzolka J; Olbromski M; Rzechonek A; Dziegiel P; Podhorska-Okolow M
    Anticancer Res; 2018 Feb; 38(2):723-736. PubMed ID: 29374696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer.
    Li J; Zhang JT; Jiang X; Shi X; Shen J; Feng F; Chen J; Liu G; He P; Jiang J; Tsang LL; Wang Y; Rosell R; Jiang L; He J; Chan HC
    Int J Oncol; 2015 May; 46(5):2107-15. PubMed ID: 25760446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
    Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W
    Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation status of Fas-associated death domain-containing protein regulates telomerase activity and strongly correlates with prostate cancer outcomes.
    Matsumura Y; Shimada K; Tanaka N; Fujimoto K; Hirao Y; Konishi N
    Pathobiology; 2009; 76(6):293-302. PubMed ID: 19955841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
    Gao BB; Wang SX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. mTOR and PTEN expression in non-small cell lung cancer: analysis by real-time fluorescence quantitative polymerase chain reaction and immunohistochemistry.
    Wang L; Yue W; Zhang L; Zhao X; Wang Y; Xu S
    Surg Today; 2012 May; 42(5):419-25. PubMed ID: 22127531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.